184 related articles for article (PubMed ID: 28335614)
1. Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):80-86. PubMed ID: 28335614
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Am J Vet Res; 2017 Aug; 78(8):946-953. PubMed ID: 28738012
[TBL] [Abstract][Full Text] [Related]
3. Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.
Unger GM; Kren BT; Korman VL; Kimbrough TG; Vogel RI; Ondrey FG; Trembley JH; Ahmed K
Mol Cancer Ther; 2014 Aug; 13(8):2018-29. PubMed ID: 24867250
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
5. A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors.
Chu S; Wylie TN; Wylie KM; Johnson GC; Skidmore ZL; Fleer M; Griffith OL; Bryan JN
Vet Microbiol; 2020 Jan; 240():108491. PubMed ID: 31902496
[TBL] [Abstract][Full Text] [Related]
6. CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.
Ahmed K; Kren BT; Abedin MJ; Vogel RI; Shaughnessy DP; Nacusi L; Korman VL; Li Y; Dehm SM; Zimmerman CL; Niehans GA; Unger GM; Trembley JH
Oncotarget; 2016 Sep; 7(38):61789-61805. PubMed ID: 27557516
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma.
Noall L; Lee S; Burton JH; Marquardt TM; Cermak J; Thombs LA; Rogic AM; Bryan JN; Chu S
Vet Comp Oncol; 2023 Sep; 21(3):509-519. PubMed ID: 37243409
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma.
Wiles V; Hohenhaus A; Lamb K; Zaidi B; Camps-Palau M; Leibman N
J Feline Med Surg; 2017 Feb; 19(2):185-193. PubMed ID: 26755491
[TBL] [Abstract][Full Text] [Related]
9. Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma.
Lundberg AP; Tran Hoang C; Billhymer A; Selting KA
Vet Comp Oncol; 2022 Dec; 20(4):788-796. PubMed ID: 35561080
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
11. Investigation of immune cell markers in feline oral squamous cell carcinoma.
Sparger EE; Murphy BG; Kamal FM; Arzi B; Naydan D; Skouritakis CT; Cox DP; Skorupski K
Vet Immunol Immunopathol; 2018 Aug; 202():52-62. PubMed ID: 30078599
[TBL] [Abstract][Full Text] [Related]
12. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma.
Evans SM; LaCreta F; Helfand S; VanWinkle T; Curran WJ; Brown DQ; Hanks G
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):703-8. PubMed ID: 1825993
[TBL] [Abstract][Full Text] [Related]
13. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
14. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
15. COX-1 and COX-2 expression in feline oral squamous cell carcinoma.
Hayes A; Scase T; Miller J; Murphy S; Sparkes A; Adams V
J Comp Pathol; 2006; 135(2-3):93-99. PubMed ID: 16952367
[TBL] [Abstract][Full Text] [Related]
16. Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice.
Trembley JH; Unger GM; Korman VL; Abedin MJ; Nacusi LP; Vogel RI; Slaton JW; Kren BT; Ahmed K
PLoS One; 2014; 9(10):e109970. PubMed ID: 25333839
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
[TBL] [Abstract][Full Text] [Related]
18. RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.
Zhang F; Yang B; Shi S; Jiang X
Acta Histochem; 2014 Jul; 116(6):1000-6. PubMed ID: 24831064
[TBL] [Abstract][Full Text] [Related]
19. Expression of mPGES1 and p16 in feline and human oral squamous cell carcinoma: A comparative oncology approach.
Nasry WHS; Jones K; Rodriguez-Lecompte JC; Tesch M; Martin CK
Vet Comp Oncol; 2024 Jun; 22(2):204-216. PubMed ID: 38378135
[TBL] [Abstract][Full Text] [Related]
20. Investigation of multiple Felis catus papillomavirus types (-1/-2/-3/-4/-5/-6) DNAs in feline oral squamous cell carcinoma: a multicentric study.
Altamura G; Cuccaro B; Eleni C; Strohmayer C; Brandt S; Borzacchiello G
J Vet Med Sci; 2022 Jun; 84(6):881-884. PubMed ID: 35431284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
